Cytosolic Malic Enzyme 1 (ME1) Mediates High Fat Diet-Induced Adiposity, Endocrine Profile, and Gastrointestinal Tract Proliferation-Associated Biomarkers in Male Mice

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Al Dwairi, Ahmed ^a   Pabona, John Mark P ^a,c   Simmen, Rosalia C M ^a,b,c   Simmen, Frank A ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CASEIN; CYCLIN D1; FATTY ACID SYNTHASE; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; KI 67 ANTIGEN; LEPTIN; MALATE DEHYDROGENASE (DECARBOXYLATING); MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; SOYBEAN PROTEIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY GROWTH; CALORIC INTAKE; CANCER RISK; CANCER SUSCEPTIBILITY; CELL SIZE; COLON; COLON CANCER; CONTROLLED STUDY; FATTY LIVER; GENE EXPRESSION; GENOTYPE; INSULIN BLOOD LEVEL; INTESTINE CRYPT; LIPID DIET; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN INTAKE; RETROPERITONEAL FAT; RISK REDUCTION; WEIGHT REDUCTION; WILD TYPE;

ADIPOCYTES; ADIPOSITY; ANIMALS; BODY WEIGHT; DIET, HIGH-FAT; GASTROINTESTINAL TRACT; INSULIN; LEPTIN; MALATE DEHYDROGENASE; MALE; MICE; MICE, MUTANT STRAINS; SOYBEAN PROTEINS;

MUS; RATTUS;

EID: 84867132768     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046716     Document Type: Article

References (61)

1. Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F, (2007) Metabolic Syndrome: From Global Epidemiology to Individualized Medicine. Clin Pharmacol Ther 82: 509-524.
2. Malnick SDH, Knobler H, (2006) The medical complications of obesity. QJM 99: 565-579.
3. Giovannucci E, (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. The American Journal of Clinical Nutrition 86: 836S-842S.
4. Brownell KD, Stuckler D, Yach D (2006) Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nature Medicine 12: 62. Article.
5. Guri AJ, Bassaganya-Riera J, (2011) Systemic effects of white adipose tissue dysregulation and obesity-related inflammation. Obesity (Silver Spring) 19: 689-700.
6. Beales IL, Ogunwobi OO, (2007) Leptin synergistically enhances the anti-apoptotic and growth-promoting effects of acid in OE33 oesophageal adenocarcinoma cells in culture. Mol Cell Endocrinol 274: 60-68.
7. Endo H, Hosono K, Uchiyama T, Sakai E, Sugiyama M, et al. (2011) Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut 60: 1363-1371.
8. Xiao R, Su Y, Simmen RC, Simmen FA, (2008) Dietary soy protein inhibits DNA damage and cell survival of colon epithelial cells through attenuated expression of fatty acid synthase. Am J Physiol Gastrointest Liver Physiol 294: G868-G876.
9. Menendez JA, Lupu R, (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7: 763-777.
10. Menendez JA, Vazquez-Martin A, Ortega FJ, Fernandez-Real JM, (2009) Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. Clin Chem 55: 425-438.
11. Menendez JA, Lupu R, (2004) Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells. Arch Immunol Ther Exp (Warsz) 52: 414-426.
12. Kersten S, (2001) Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep 2: 282-286.
13. Abramson HN, (2011) The Lipogenesis Pathway as a Cancer Target. J Med Chem 54: 5615-5638 doi: 10.1021/jm2005805.
14. Chuang HY, Chang YF, Hwang JJ, (2011) Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal. Biomedicine & Pharmacotherapy 65: 286-292 doi: 10.1016/j.biopha.2011.02.016.
15. Beckers A, Organe S, Timmermans L, Scheys K, Peeters A, et al. (2007) Chemical Inhibition of Acetyl-CoA Carboxylase Induces Growth Arrest and Cytotoxicity Selectively in Cancer Cells. Cancer Research 67: 8180-8187.
16. Trujillo ME, Scherer PE, (2006) Adipose Tissue-Derived Factors: Impact on Health and Disease. Endocrine Reviews 27: 762-778.
17. Sugiyama M, Takahashi H, Hosono K, Endo H, Kato S, et al. (2009) Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol 34: 339-344.
18. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS, (2005) Low Plasma Adiponectin Levels and Risk of Colorectal Cancer in Men: A Prospective Study. Journal of the National Cancer Institute 97: 1688-1694.
19. Mutoh M, Teraoka N, Takasu S, Takahashi M, Onuma K, et al. (2011) Loss of adiponectin promotes intestinal carcinogenesis in Min and wild-type mice. Gastroenterology 140: 2000-8, 2008.
20. Labruna G, Pasanisi F, Nardelli C, Caso R, Vitale DF, et al. (2011) High leptin/adiponectin ratio and serum triglycerides are associated with an "at-risk" phenotype in young severely obese patients. Obesity (Silver Spring) 19: 1492-1496.
21. Satoh N, Naruse M, Usui T, Tagami T, Suganami T, et al. (2004) Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 27: 2488-2490.
22. Wise EM Jr, Ball EG, (1964) Malic enzyme and lipogenesis. Proc Natl Acad Sci U S A 52: 1255-1263.
23. ez-Roux G, Banfi S, Sultan M, Geffers L, Anand S, et al. (2011) A high-resolution anatomical atlas of the transcriptome in the mouse embryo. PLoS Biol 9: e1000582.
24. Lee CY, Lee SM, Lewis S, Johnson FM, (1980) Identification and biochemical analysis of mouse mutants deficient in cytoplasmic malic enzyme. Biochemistry 19: 5098-5103 doi: 10.1021/bi00563a025.
25. Zhong H, Beaulaurier J, Lum PY, Molony C, Yang X, et al. (2010) Liver and adipose expression associated SNPs are enriched for association to type 2 diabetes. PLoS Genet 6: e1000932.
26. Yang X, Deignan JL, Qi H, Zhu J, Qian S, et al. (2009) Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nat Genet 41: 415-423.
27. Huang XF, Liu Y, Rahardjo GL, Mclennan PL, Tapsell LC, et al. (2008) Effects of diets high in whey, soy, red meat and milk protein on body weight maintenance in diet-induced obesity in mice. Nutrition & Dietetics 65: S53-S59. 10.1111/j.1747-0080.2008.00262.x.
28. Xiao R, Badger TM, Simmen FA, (2005) Dietary exposure to soy or whey proteins alters colonic global gene expression profiles during rat colon tumorigenesis. Mol Cancer 4: 1.
29. Yan L, Spitznagel EL, Bosland MC, (2010) Soy consumption and colorectal cancer risk in humans: a meta-analysis. Cancer Epidemiol Biomarkers Prev 19: 148-158.
30. Torre-Villalvazo I, Tovar AR, Ramos-Barragan VE, Cerbon-Cervantes MA, Torres N, (2008) Soy protein ameliorates metabolic abnormalities in liver and adipose tissue of rats fed a high fat diet. J Nutr 138: 462-468.
31. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
32. Dave B, Eason RR, Till SR, Geng Y, Velarde MC, et al. (2005) The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. Carcinogenesis 26: 1793-1803. bgi131 [pii];doi:10.1093/carcin/bgi131.
33. Brown ML, Wise LS, Rubin CS, (1988) The molecular basis for a cytosolic malic enzyme null mutation. Malic enzyme mRNA from MOD-1 null mice contains an internal in-frame duplication that extends the coding sequence by 522 nucleotides. J Biol Chem 263: 4494-4499.
34. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M, (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371: 569-578.
35. Miyamoto S, Tanaka T, Murakami A, (2010) Increased visceral fat mass and insulin signaling in colitis-related colon carcinogenesis model mice. Chem Biol Interact 183: 271-275.
36. Simmen FA, Mercado CP, Zavacki AM, Huang SA, Greenway AD, et al. (2010) Soy protein diet alters expression of hepatic genes regulating fatty acid and thyroid hormone metabolism in the male rat. J Nutr Biochem 21: 1106-1113.
37. Su Y, Shankar K, Simmen RC, (2009) Early soy exposure via maternal diet regulates rat mammary epithelial differentiation by paracrine signaling from stromal adipocytes. J Nutr 139: 945-951.
38. Xiao R, Hennings LJ, Badger TM, Simmen FA, (2007) Fetal programming of colon cancer in adult rats: correlations with altered neonatal growth trajectory, circulating IGF-I and IGF binding proteins, and testosterone. J Endocrinol 195: 79-87.
39. Bhathena SJ, Velasquez MT, (2002) Beneficial role of dietary phytoestrogens in obesity and diabetes. The American Journal of Clinical Nutrition 76: 1191-1201.
40. Vinall RL, Hwa K, Ghosh P, Pan CX, Lara PN Jr, et al. (2007) Combination treatment of prostate cancer cell lines with bioactive soy isoflavones and perifosine causes increased growth arrest and/or apoptosis. Clin Cancer Res 13: 6204-6216.
41. Kim EJ, Shin HK, Park JH, (2005) Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein. Journal of Medicinal Food 8 431-43810.1089/jmf.2005.8.431.
42. Johnson SM, Gulhati P, Rampy BA, Han Y, Rychahou PG, et al. (2010) Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer. J Am Coll Surg 210: 767-768.
43. Zhang YJ, Dai Q, Sun DF, Xiong H, Tian XQ, et al. (2009) mTOR signaling pathway is a target for the treatment of colorectal cancer. Ann Surg Oncol 16: 2617-2628.
44. Zhan Y, Ginanni N, Tota MR, Wu M, Bays NW, et al. (2008) Control of Cell Growth and Survival by Enzymes of the Fatty Acid Synthesis Pathway in HCT-116 Colon Cancer Cells. Clinical Cancer Research 14: 5735-5742.
45. Kearney KE, Pretlow TG, Pretlow TP, (2009) Increased expression of fatty acid synthase in human aberrant crypt foci: Possible target for colorectal cancer prevention. International Journal of Cancer 125 249-25210.1002/ijc.24356.
46. Zhang HH, Huang J, Duvel K, Boback B, Wu S, et al. (2009) Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway. PLoS ONE 4: e6189 doi:10.1371/journal.pone.0006189.
47. Richardson DK, Czech MP, (1979) Diminished activities of fatty acid synthesis enzymes in insulin-resistant adipocytes from spontaneously obese rats. Horm Metab Res 11: 427-431.
48. Heart E, Cline GW, Collis LP, Pongratz RL, Gray JP, et al. (2009) Role for malic enzyme, pyruvate carboxylation, and mitochondrial malate import in glucose-stimulated insulin secretion. American Journal of Physiology- Endocrinology And Metabolism 296: E1354-E1362.
49. Nakamura Y, Yogosawa S, Izutani Y, Watanabe H, Otsuji E, et al. (2009) A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy. Mol Cancer 8: 100.
50. Yamaji T, Iwasaki M, Sasazuki S, Tsugane S, (2010) Interaction between Adiponectin and Leptin Influences the Risk of Colorectal Adenoma. Cancer Research 70: 5430-5437.
51. Huang XF, Chen JZ, (2009) Obesity, the PI3K/Akt signal pathway and colon cancer. Obesity Reviews 10: 610-616. 10.1111/j.1467-789X.2009.00607.x.
52. Jenab M, Riboli E, Cleveland RJ, Norat T, Rinaldi S, et al. (2007) Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 121: 368-376.
53. Tran TT, Medline A, Bruce WR, (1996) Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 5: 1013-1015.
54. Stattin P, Lukanova A, Biessy C, Soderberg S, Palmqvist R, et al. (2004) Obesity and colon cancer: does leptin provide a link? Int J Cancer 109: 149-152.
55. Fujisawa T, Endo H, Tomimoto A, Sugiyama M, Takahashi H, et al. (2008) Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 57: 1531-1538.
56. Otani K, Kitayama J, Yasuda K, Nio Y, Iwabu M, et al. (2010) Adiponectin suppresses tumorigenesis in Apc(Min)(/+) mice. Cancer Lett 288: 177-182.
57. Finucane FM, Luan J, Wareham NJ, Sharp SJ, O'Rahilly S, et al. (2009) Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 52: 2345-2349.
58. Inoue M, Yano M, Yamakado M, Maehata E, Suzuki S, (2006) Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia. Metabolism 55: 1248-1254.
59. Hakkak R, Al-Dwairi A, Fuchs GJ, Korourian S, Simmen FA (2012) Dietary soy protein induces hepatic lipogenic enzyme gene expression while suppressing hepatosteatosis in obese female Zucker rats bearing DMBA-initiated mammary tumors. Genes Nutr. doi:10.1007/s12263-012-0294-6.
60. O'Brien LE, Soliman SS, Li X, Bilder D, (2011) Altered modes of stem cell division drive adaptive intestinal growth. Cell 147: 603-614.
61. Carvalho E, Jansson PA, Axelsen M, Eriksson JW, Huang X, et al. (1999) Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM. The FASEB Journal 13: 2173-2178.